Cargando…
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics
OBJECTIVES: The systemic autoinflammatory diseases are rare conditions; to date, data on coronavirus disease 2019 (COVID-19) infection and vaccination safety are scarce. Agents targeting innate immune pathways have transformed the management of affected patients, and their outcomes are of wider inte...
Autores principales: | Peet, Claire J, Papadopoulou, Charalampia, Sombrito, Bella Ruth M, Wood, Michael R, Lachmann, Helen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397842/ https://www.ncbi.nlm.nih.gov/pubmed/34466775 http://dx.doi.org/10.1093/rap/rkab043 |
Ejemplares similares
-
Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center
por: Peet, Claire J., et al.
Publicado: (2022) -
Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review
por: Garg, Suchika, et al.
Publicado: (2019) -
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
por: Lewis, Sarah S., et al.
Publicado: (2020) -
Developments in the scientific and clinical understanding of autoinflammatory disorders
por: Lachmann, Helen J, et al.
Publicado: (2009) -
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
por: Clark, Kristina E N, et al.
Publicado: (2020)